{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:05:58Z","timestamp":1773659158691,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T00:00:00Z","timestamp":1506988800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"County Council of V\u00e4sterbotten (SE)","award":["130000SEK"],"award-info":[{"award-number":["130000SEK"]}]},{"name":"Heart Foundation of Northern Sweden (SE)","award":["25000SEK"],"award-info":[{"award-number":["25000SEK"]}]},{"name":"Swedish Society of Pulmonary Hypertension (SE)","award":["25000SEK"],"award-info":[{"award-number":["25000SEK"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00380-017-1055-7","type":"journal-article","created":{"date-parts":[[2017,10,3]],"date-time":"2017-10-03T01:48:36Z","timestamp":1506995316000},"page":"255-263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4980-8230","authenticated-orcid":false,"given":"Anna","family":"Sandqvist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rn","family":"Schneede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kylhammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Henrohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Hedeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Bondesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"R\u00e5degran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Wikstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,3]]},"reference":[{"issue":"1","key":"1055_CR1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Sanchez MAG, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barber\u00e0 J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck-Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, V\u00f6ller H, Luis Zamorano J (2016) 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67\u2013119","journal-title":"Eur Heart J"},{"issue":"6122","key":"1055_CR2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","volume":"327","author":"RM Palmer","year":"1987","unstructured":"Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327(6122):524\u2013526","journal-title":"Nature"},{"issue":"8793","key":"1055_CR3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","volume":"339","author":"P Vallance","year":"1992","unstructured":"Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339(8793):572\u2013575","journal-title":"Lancet"},{"issue":"10","key":"1055_CR4","doi-asserted-by":"crossref","first-page":"E1177","DOI":"10.1152\/ajpendo.00284.2012","volume":"303","author":"YC Luiking","year":"2012","unstructured":"Luiking YC, Ten Have GAM, Wolfe RR, Deutz NEP (2012) Arginine de novo and nitric oxide production in disease states. Am J Physiol Endocrinol Metab 303(10):E1177\u2013E1189","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"1055_CR5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1096\/fj.04-3223fje","volume":"19","author":"S Pullamsetti","year":"2005","unstructured":"Pullamsetti S, Kiss L, Ghofrani HA, Voswinckel R, Haredza P, Klepetko W, Aigner C, Fink L, Muyal JP, Weissmann N, Grimminger F, Seeger W, Schermuly RT (2005) Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. FASEB J 19(9):1175\u20131177","journal-title":"FASEB J"},{"key":"1055_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2466-9-5","volume":"9","author":"D Zakrzewicz","year":"2009","unstructured":"Zakrzewicz D, Eickelberg O (2009) From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases. BMC Pulm Med 9:5","journal-title":"BMC Pulm Med"},{"issue":"6","key":"1055_CR7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.phrs.2009.08.002","volume":"60","author":"T Teerlink","year":"2009","unstructured":"Teerlink T, Luo Z, Palm F, Wilcox CS (2009) Cellular ADMA: regulation and action. Pharmacol Res 60(6):448\u2013460","journal-title":"Pharmacol Res"},{"issue":"3","key":"1055_CR8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pharmthera.2007.03.002","volume":"114","author":"SM Bode-B\u00f6ger","year":"2007","unstructured":"Bode-B\u00f6ger SM, Scalera F, Ignarro LJ (2007) The l-arginine paradox: importance of the l-arginine\/asymmetrical dimethylarginine ratio. Pharmacol Ther 114(3):295\u2013306","journal-title":"Pharmacol Ther"},{"issue":"6","key":"1055_CR9","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","volume":"293","author":"F Palm","year":"2007","unstructured":"Palm F, Onozato ML, Luo Z, Wilcox CS (2007) Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 293(6):H3227\u2013H3245","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Pt 1","key":"1055_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj3430209","volume":"343","author":"JM Leiper","year":"1999","unstructured":"Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, Vallance P (1999) Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J 343(Pt 1):209\u2013214","journal-title":"Biochem J"},{"issue":"1","key":"1055_CR11","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1177\/1358836X0501000107","volume":"10","author":"V-P Valkonen","year":"2005","unstructured":"Valkonen V-P, Tuomainen T-P, Laaksonen R (2005) DDAH gene and cardiovascular risk. Vasc Med 10(1):S45\u2013S48","journal-title":"Vasc Med"},{"issue":"3\u20134","key":"1055_CR12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.prostaglandins.2006.06.005","volume":"80","author":"P Blardi","year":"2006","unstructured":"Blardi P, de Lalla A, Pieragalli D, De Franco V, Meini S, Ceccatelli L, Auteri A (2006) Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease. Prostaglandins Other Lipid Mediat 80(3\u20134):175\u2013182","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"3","key":"1055_CR13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1517\/17425250902785172","volume":"5","author":"C Wadham","year":"2009","unstructured":"Wadham C, Mangoni AA (2009) Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease. Expert Opin Drug Metab Toxicol 5(3):303\u2013319","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"1055_CR14","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.ATV.0000168414.06853.f0","volume":"25","author":"JT Kielstein","year":"2005","unstructured":"Kielstein JT, Bode-B\u00f6ger SM, Hesse G, Martens-Lobenhoffer J, Takacs A, Fliser D, Hoeper MM (2005) Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 25(7):1414\u20131418","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"1055_CR15","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1164\/rccm.200702-278OC","volume":"176","author":"N Skoro-Sajer","year":"2007","unstructured":"Skoro-Sajer N, Mittermayer F, Panzenboeck A, Bonderman D, Sadushi R, Hitsch R, Jakowitsch J, Klepetko W, Kneussi MP, Wolzt M, Lang IM (2007) Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 176(11):1154\u20131160","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"1055_CR16","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3324\/haematol.12928","volume":"93","author":"PP Landburg","year":"2008","unstructured":"Landburg PP, Teerlink T, van Beers EJ, Muskiet FAJ, Kappers-Klunne MC, van Esser JWJ, Mac Gillavry MR, Biemond BJ, Brandjes DPM, Duits AJ, Schnog JJ (2008) Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension. Haematologica 93(9):1410\u20131412","journal-title":"Haematologica"},{"issue":"11","key":"1055_CR17","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/rheumatology\/ken346","volume":"47","author":"T Dimitroulas","year":"2008","unstructured":"Dimitroulas T, Giannakoulas G, Sfetsios T, Karvounis H, Dimitroula H, Koliakos G, Settas L (2008) Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension. Rheumatol (Oxford) 47(11):1682\u20131685","journal-title":"Rheumatol (Oxford)"},{"issue":"8","key":"1055_CR18","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00246-012-0321-9","volume":"33","author":"C Sanli","year":"2012","unstructured":"Sanli C, Oguz D, Olgunturk R, Tunaoglu FS, Kula S, Pasaoglu H, Cevik A (2012) Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease. Pediatr Cardiol 33(8):1323\u20131331","journal-title":"Pediatr Cardiol"},{"issue":"13","key":"1055_CR19","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jacc.2011.12.022","volume":"59","author":"Z Shao","year":"2012","unstructured":"Shao Z, Wang Z, Shrestha K, Thakur A, Borowski AG, Sweet W, Thomas JD, Moravec CS, Hazen SL, Tang WHW (2012) Pulmonary hypertension associated with advanced systolic heart failure: dysregulated arginine metabolism and importance of compensatory dimethylarginine dimethylaminohydrolase-1. J Am Coll Cardiol 59(13):1150\u20131158","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1055_CR20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00005344-200104000-00016","volume":"37","author":"M Gorenflo","year":"2001","unstructured":"Gorenflo M, Zheng C, Werle E, Fiehn W, Ulmer HE (2001) Plasma levels of asymmetrical dimethyl-l-arginine in patients with congenital heart disease and pulmonary hypertension. J Cardiovasc Pharmacol 37(4):489\u2013492","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"1055_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/QAD.0000000000000124","volume":"28","author":"RV Parikh","year":"2014","unstructured":"Parikh RV, Scherzer R, Nitta EM, Leone A, Hur S, Mistry V, Macgregor JS, Martin JN, Deeks SG, Ganz P, Hsue PY (2014) Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection. AIDS 28(4):511\u2013519","journal-title":"AIDS"},{"issue":"11","key":"1055_CR22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/CIRCULATIONAHA.110.017038","volume":"123","author":"JL Zweier","year":"2011","unstructured":"Zweier JL, Talukder MAH (2011) Targeting dimethylarginine dimethylaminohydrolases in pulmonary arterial hypertension: a new approach to improve vascular dysfunction? Circulation 123(11):1156\u20131158","journal-title":"Circulation"},{"key":"1055_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.vph.2015.04.010","volume":"73","author":"D Henrohn","year":"2015","unstructured":"Henrohn D, Sandqvist A, Eger\u00f6d H, Hedeland M, Wernroth L, Bondesson U, Wikstr\u00f6m G (2015) Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension. Vasc Pharmacol 73:71\u201377","journal-title":"Vasc Pharmacol"},{"issue":"1","key":"1055_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111\u2013117","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1055_CR25","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cvr\/cvt036","volume":"98","author":"J Pernow","year":"2013","unstructured":"Pernow J, Jung C (2013) Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 98(3):334\u2013343","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1055_CR26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/679720","volume":"5","author":"CC Kao","year":"2015","unstructured":"Kao CC, Wedes SH, Hsu JW, Bohren KM, Comhair SAA, Jahoor F, Erzurum SC (2015) Arginine metabolic endotypes in pulmonary arterial hypertension. Pulm Circ 5(1):124\u2013134","journal-title":"Pulm Circ"},{"issue":"14","key":"1055_CR27","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1096\/fj.04-2317fje","volume":"18","author":"W Xu","year":"2004","unstructured":"Xu W, Kaneko FT, Zheng S, Comhair SAA, Janocha AJ, Goggans T, Thunnissen FBJ, Farver C, Hazen SL, Jennings C, Dweik RA, Arroliga AC, Erzurum SC (2004) Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 18(14):1746\u20131748","journal-title":"FASEB J"},{"issue":"8","key":"1055_CR28","doi-asserted-by":"crossref","first-page":"E1609","DOI":"10.3390\/ijms18081609","volume":"18","author":"C Jung","year":"2017","unstructured":"Jung C, Gr\u00fcn K, Betge S, Pernow J, Kelm M, Muessig J, Masyuk M, Kuethe F, Ndongson-Dongmo B, Bauer R, Lauten A, Schulze PC, Berndt A, Franz M (2017) Arginase inhibition reverses monocrotaline-induced pulmonary hypertension. Int J Mol Sci 18(8):E1609","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1055_CR29","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1213\/ANE.0000000000001378","volume":"123","author":"J Steppan","year":"2016","unstructured":"Steppan J, Tran HT, Bead VR, Oh YJ, Sikka G, Bivalacqua TJ, Burnett AL, Berkowitz DE, Santhanam L (2016) Arginase inhibition reverses endothelial dysfunction, pulmonary hypertension, and vascular stiffness in transgenic sickle cell mice. Anesth Analg 123(3):652\u2013658","journal-title":"Anesth Analg"},{"issue":"10","key":"1055_CR30","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/iub.1557","volume":"68","author":"L Hu","year":"2016","unstructured":"Hu L, Gao Y, Cao Y, Zhang Y, Xu M, Wang Y, Jing Y, Guo S, Jing F, Hu X, Zhu Z (2016) Identification of arginine and its \u201cDownstream\u201d molecules as potential markers of breast cancer. IUBMB Life 68(10):817\u2013822","journal-title":"IUBMB Life"},{"issue":"5","key":"1055_CR31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ajcn\/81.5.1142","volume":"81","author":"YLJ Vissers","year":"2005","unstructured":"Vissers YLJ, Dejong CHC, Luiking YC, Fearon KCH, von Meyenfeldt MF, Deutz NEP (2005) Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am J Clin Nutr 81(5):1142\u20131146","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1055_CR32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1024\/0301-1526.37.1.61","volume":"37","author":"J Beyer","year":"2008","unstructured":"Beyer J, Kolditz M, Ewert R, Rubens C, Opitz C, Schellong S, Hoeffken G, Halank M (2008) l-arginine plasma levels and severity of idiopathic pulmonary arterial hypertension. VASA 37(1):61\u201367","journal-title":"VASA"},{"issue":"1","key":"1055_CR33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2014.12.030","volume":"239","author":"Y Notsu","year":"2015","unstructured":"Notsu Y, Yano S, Shibata H, Nagai A, Nabika T (2015) Plasma arginine\/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study. Atherosclerosis 239(1):61\u201366","journal-title":"Atherosclerosis"},{"issue":"1","key":"1055_CR34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5603\/CJ.2012.0006","volume":"19","author":"M Celik","year":"2012","unstructured":"Celik M, Iyisoy A, Celik T, Yilmaz MI, Yuksel UC, Yaman H (2012) The relationship between l-arginine\/ADMA ratio and coronary collateral development in patients with low glomerular filtration rate. Cardiol J 19(1):29\u201335","journal-title":"Cardiol J"},{"issue":"3","key":"1055_CR35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2013.07.004","volume":"140","author":"L Rochette","year":"2013","unstructured":"Rochette L, Lorin J, Zeller M, Guilland J-C, Lorgis L, Cottin Y, Vergely C (2013) Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? Pharmacol Ther 140(3):239\u2013257","journal-title":"Pharmacol Ther"},{"issue":"6","key":"1055_CR36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.phrs.2009.07.016","volume":"60","author":"AJ Pope","year":"2009","unstructured":"Pope AJ, Karuppiah K, Cardounel AJ (2009) Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production. Pharmacol Res 60(6):461\u2013465","journal-title":"Pharmacol Res"},{"issue":"3","key":"1055_CR37","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3892\/mmr.2014.2968","volume":"11","author":"AV Treuer","year":"2015","unstructured":"Treuer AV, Gonzalez DR (2015) Nitric oxide synthases, S-nitrosylation and cardiovascular health: from molecular mechanisms to therapeutic opportunities (review). Mol Med Rep 11(3):1555\u20131565","journal-title":"Mol Med Rep"},{"issue":"3","key":"1055_CR38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/CS20110013","volume":"122","author":"N L\u00fcneburg","year":"2012","unstructured":"L\u00fcneburg N, von Holten R-A, T\u00f6pper RF, Schwedhelm E, Maas R, B\u00f6ger RH (2012) Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function. Clin Sci 122(3):105\u2013111","journal-title":"Clin Sci"},{"issue":"4","key":"1055_CR39","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.2009.07658.x","volume":"145","author":"GJ Kato","year":"2009","unstructured":"Kato GJ, Wang Z, Machado RF, Blackwelder WC, Taylor JG, Hazen SL (2009) Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br J Haematol 145(4):506\u2013513","journal-title":"Br J Haematol"},{"issue":"4","key":"1055_CR40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ncpneph0143","volume":"2","author":"C Baylis","year":"2006","unstructured":"Baylis C (2006) Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol 2(4):209\u2013220","journal-title":"Nat Clin Pract Nephrol"},{"issue":"1","key":"1055_CR41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ndt\/gfq395","volume":"26","author":"JT Kielstein","year":"2011","unstructured":"Kielstein JT, Veldink H, Martens-Lobenhoffer J, Haller H, Burg M, Lorenzen JM, Lichtinghagen R, Bode-B\u00f6ger SM, Kliem V (2011) SDMA is an early marker of change in GFR after living-related kidney donation. Nephrol Dial Transplant 26(1):324\u2013328","journal-title":"Nephrol Dial Transplant"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-017-1055-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1055-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-017-1055-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,25]],"date-time":"2018-02-25T21:35:07Z","timestamp":1519594507000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-017-1055-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1007\/s00380-017-1055-7","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,3]]}}}